Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratympanic dexamethasone versus methylprednisolone for sudden sensorineural hearing loss
IRCT20260521069471N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in acute sensorineural hearing loss comparing Intratympanic dexamethasone with Intratympanic methylprednisolone (2 arms). Started Jun 2026; status: completed.
02
Drugs
dexamethasonemethylprednisolone
03
Conditions
acute sensorineural hearing loss
Beyond the preview
Go deeper on IRCT20260521069471N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260521069471N1.